Information portal on various topics of management of public resources of the Portuguese State

Project sheet

Name

Assistant Researcher in Biochemistry and Biophysics,

Total project amount

246,79 thousand €

Amount paid

0 €

Non-refundable funding

246,79 thousand €

Loan funding

0 €

Start date

01.02.2025

Expected end date

31.03.2026

Dimension

Resilience

Component

Qualifications and Skills

Investment

Science Plus Training

Operation code

02/C06-i06/2024.P2023.11076.TENURE.005

Summary

Job Description: We are seeking a highly motivated and skilled Researcher in Molecular Mechanisms of Metabolic Diseases to identify novel druggable therapeutic targets and nutraceutical bioactive compounds with therapeutic potential, to join our dynamic team at NOVA FCT/ UCIBIO/i4HB . The successful candidate will be responsible for conducting cutting-edge research in the areas of Molecular Mechanisms of Metabolic Diseases and Identification of Therapeutic Targets, with a specific focus on Diabetes and associated Metabolic Diseases.Key tasks include discovering novel therapeutic targets and identifying pharmaceutical and nutraceutical bioactive compounds to modulate the putative disease targets, interfere with disease mechanisms and test effectiveness in preventing or curing the disease in question, designing and executing pre-clinical studies in rodents and designing human interventional studies and clinical trials. The researcher will contribute to the advancement of scientific knowledge and the development of innovative and sustainable solutions in the field.Responsibilities:Conduct clinical observational studies in humans to collect biopsies and patient information.Design workflow for analyses of human samples using advanced omics and microscopy techniques.Analyse and interpret omics data to identify novel potential therapeutic targets.Design and execute experiments to decipher protein signalling networks involved in disease mechanisms.Investigate molecular mechanisms of interfering bioactive compounds and optimize experimental protocols.Conduct in-depth analyses of molecular signalling cascades using advanced characterization techniques to decipher mechanisms of diseases with the objective of discovering new preventions and cures.Set up and execute pre-clinical studies in rodents to test therapies on proposed therapeutic targets.Collaborate with interdisciplinary teams to integrate findings into broader research initiatives.Lead publication of research findings in reputable scientific journals.Stay abreast of the latest developments in Molecular Mechanisms of Metabolic Diseased and related fields.Scientific Profile: The ideal candidate will possess the following qualifications and attributes:Ph.D. in Biomedical Sciences - branch/specialty Morphological Sciences, with strong documented focus on Diabetes.Proven expertise in deciphering cell signalling processes relating to metabolic diseases and diabetes, and expertise in experimental design to decipher molecular signalling pathways with a track record of successful projects.Extensive knowledge of advanced microscopy techniques.Proficiency in utilizing bioinformatic analytical techniques for high-throughput data including transcriptomics, proteomics and metabolomics.Strong publication record in reputable scientific journals, demonstrating the ability to contribute novel insights to the field.Excellent communication and collaboration skills, with the ability to work effectively in a team environment.Rationale: The recruitment for this position aligns with the strategic goals of NOVA FCT/ UCIBIO Research Unit to advance research excellence on thematic line TL2 (Diagnostics, Drug Discovery and Development) dedicated to finding innovative therapies for incurable diseases through target characterization and identification of new biologically active molecules, contributing to sustainable health strategies. The intersection of acquisition and interpretation of omics data, with clear validating strategies, integrated with novel uses of nutraceutical bioactive compounds represents a burgeoning area of scientific exploration with promising applications in drug discovery, novel nutraceuticals, and sustainable health interventions and technologies.The expertise of the successful candidate will significantly contribute to ongoing research projects and strengthen our institutional capabilities in these critical areas. Furthermore, the hire will enhance collaboration with external partners, foster academic-industry relationships, and contribute to the training of the next generation of researchers in Disease Pathways & Biomarkers for Diagnostics, Drug Discovery and Development. This position reflects our commitment to innovation and scientific leadership, positioning NOVA FCT/ UCIBIO/i4HB at the forefront of advancements in Disease Target and Drug Discovery and Development and related disciplines.

Beneficiaries

Within the scope of the Recovery and Resilience Plan, two types of beneficiaries are responsible for carrying out the projects and using the funding provided. Due to their similar role, the reference to these two types of beneficiaries has been simplified and unified under the term "Beneficiary".
The two types are::
  • Direct Beneficiaries are those whose funding and projects to implement are part of the Recovery and Resilience Plan that has been negotiated and approved by the European Union;
  • Final Beneficiaries are those whose funding and projects to implement are approved following a selection process through Calls for Applications.

Call for applications

As part of the Call for Applications, submissions are requested to select the projects and final beneficiaries to whom funding will be awarded. Specific selection criteria are defined for each call, which must be reflected in the applications submitted and assessed.

The project is appraised on the basis of its compliance with the selection criteria laid down in the calls for applications, and a final score may be awarded, where applicable.

Final evaluation score

9,3
Important note

The components for calculating the assessment score can be found in the selection criteria document mentioned below.

Selection criteria

The funding selection criteria to which this project and its final beneficiary were subject and its score can be found in detail on the Recuperar Portugal platform.

Beneficiaries

Intermediate beneficiaries

Beneficiaries

Procurement

Beneficiaries representing public entities implement their project by signing one or more contracts with suppliers for goods or services through public procurement procedures.

To ensure and provide the utmost transparency in all these contracts, a list of the contracts that were signed under this project is available here, along with the information available on the Base.Gov platform. Please note that, according to the legislation in force at the time the contract was signed, some exceptions do not require the publication of the contracts signed on this platform, and, therefore, no information is available in such cases.

Geographic distribution

246,79 thousand €

Total amount of the project

Where was the money spent

By county

1 county financed .

  • Lisboa 246,79 thousand € ,
Source EMRP
10.02.2026
All themes
Transparency without leading